ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Investor Presentation
Revised Investor Presentation08-02-2024
08-02-2024
Zydus Wellness Results Earnings Call for Q3FY24
Conference Call with Zydus Wellness Ltd. Management and Analysts on Q3FY24 Performance and Outlook. Listen to the full earnings transcript.08-02-2024
Zydus Lifesciences gets USFDA approvals for dexamethasone tablets
Zydus Lifesciences stock rose by 1.31 per cent at 802 as of 2.50 pm08-02-2024
Q3FY24 Quarterly Result Announced for Zydus Wellness Ltd.
Packaged Foods company Zydus Wellness announced Q3FY24 results: Financial Highlights: - Zydus Wellness reported consolidated Net sales of Rs 400 crore for Q3FY24. - The company posted a Profit after Tax of Rs 0.3 crore, which includes a deferred Tax liability of Rs 3.4 crore. Brand Performance: - The Sugar Free brand maintained its dominant market share of 96% in the sugar substitute category. - Glucon-D continued to lead with a 60% market share in the Glucose powder category. - Complan saw a 16% increase in penetration at MAT level, while the Health Foods Drink Category grew by 5.8% at MAT level. Complan's market share is at 4.3%. Personal Care Segment: - In the personal care segment, Nycil remains the market leader with a 35.1% share in the prickly heat powder category. - Everyuth Scrub holds the top position with a 44.4% market share in the facial scrub category, marking an increase of 263 basis points from the previous year. - Everyuth Peel off also maintains its leading position with a 79.5% market share in the Peel off category, up by 113 basis points from last year. Result PDF08-02-2024
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation08-02-2024
ZYDUS WELLNESS LTD.-$ - 531335 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended On December 31, 2023
Unaudited financial results for the quarter and nine months ended on December 31, 202308-02-2024
ZYDUS WELLNESS LTD.-$ - 531335 - Unaudited Financial Results For The Quarter And Nine Months Ended On December 31, 2023
Unaudited financial results for the quarter and nine months ended on December 31, 202308-02-2024
Zydus Life soars to 52-week high on share buyback plan
If approved, this will be the second buyback by the company. The first was in June 202206-02-2024
ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst / Institutional Investors' call on February 8, 202430-01-2024